---
title: "Shanghai Fudan Forward S&T Co., Ltd. (600624.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/600624.SH.md"
symbol: "600624.SH"
name: "Shanghai Fudan Forward S&T Co., Ltd."
industry: "Pharmaceuticals"
datetime: "2026-03-07T00:49:00.824Z"
locales:
  - [en](https://longbridge.com/en/quote/600624.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/600624.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/600624.SH.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/600624.SH.md) | [繁體中文](https://longbridge.com/zh-HK/quote/600624.SH.md)


# Shanghai Fudan Forward S&T Co., Ltd. (600624.SH)

## Company Overview

Shanghai Fudan Forward S&T Co., Ltd engages in the medical and health, digital economy, high-tech, and other businesses. The company is involved in the research and development, production, and sales of computer systems, communication equipment, automation instruments, biotechnology, light source lighting, and other products; and import and export business. It also engages in the research and development, production, and sales of chemical raw materials, chemical pharmaceutical preparations, and traditional Chinese medicine; exporting software to Japan in the fintech sector; and development, construction, operation, and management of high-tech parks. In addition, the company provides investment and consulting services in the high-tech field; distributes car audio and high-end car care products; processes sheet metals; and develops health management systems.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | CN Market |
| Website | [www.forwardgroup.com](https://www.forwardgroup.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: D
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-03-06T04:30:08.000Z

**Overall: D (0.63)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 206 / 222 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: D

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 3.49% |  |
| Net Profit YoY | -95.18% |  |
| P/B Ratio | 5.50 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 3420979709.20 |  |
| Revenue | 660709742.06 |  |

#### Multi Score Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -17.07% | E |
| Profit Margin | -18.00% | D |
| Gross Margin | 34.74% | C |
| Revenue YoY | 3.49% | C |
| Net Profit YoY | -95.18% | E |
| Total Assets YoY | -2.36% | D |
| Net Assets YoY | -18.91% | E |
| Cash Flow Margin | -555.61% | E |
| OCF YoY | 3.49% | C |
| Turnover | 0.43 | C |
| Gearing Ratio | 56.99% | D |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Shanghai Fudan Forward S&T Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "3.49%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-95.18%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "5.50",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "3420979709.20",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "660709742.06",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-17.07%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-18.00%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "34.74%",
          "rating": "C"
        },
        {
          "name": "Revenue YoY",
          "value": "3.49%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "-95.18%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-2.36%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-18.91%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-555.61%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "3.49%",
          "rating": "C"
        },
        {
          "name": "Turnover",
          "value": "0.43",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "56.99%",
          "rating": "D"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -29.05 | 193/222 | - | - | - |
| PB | 5.56 | 195/222 | 7.64 | 6.64 | 5.78 |
| PS (TTM) | 5.23 | 125/222 | 7.52 | 6.71 | 5.49 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Xingqi Pharmaceutical (300573.SZ) | A | A | A | B | B | A |
| 02 | Hengrui Pharma (600276.SH) | A | B | C | A | B | B |
| 03 | Yunnan Baiyao (000538.SZ) | B | C | B | B | C | B |
| 04 | Salubris (002294.SZ) | B | B | C | A | B | B |
| 05 | Haisco (002653.SZ) | B | C | B | C | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/600624.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/600624.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/600624.SH/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/600624.SH/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**